Talk Small Biopharma Strategies track
Adopting a Hybrid FSP Model and eISF in a Fast-Paced Clinical Trial Environment
Tue, Feb 4, 2025 · 3:25–3:40 PM EST Rosen Shingle Creek
About this session
Galderma has implemented a hybrid Functional Service Provider (FSP) model and eISF for select clinical trials, outsourcing specific functions while still maintaining control over data and processes. This hybrid approach blends sponsor, CRO, and vendor tools and technologies. It allows increased oversight of quality and compliance and leverages in-house expertise with an expanded pool of specialized talent through the FSP provider. This presentation will highlight the pros and cons of implementing a hybrid FSP model and an eISF in a fast-paced clinical trial environment with tight timelines and lean in-house cross-functional teams.
